Marken Launches Solo For Management of Clinical Trials Distribution
“We are pleased to offer this new system to our growing number of pharmaceutical clients”, said Frank Wright, Interim President, Clinical Trials Distribution at Marken.
“Solo is fit for purpose application which incorporates all of our client’s requirements for remote storage and distribution of their clinical trial supplies. We are also excited to be launching Solo as we manage an increasing number of depots around the world”. Solo™ is purpose-built to allow a high degree of customization supporting the dynamic needs of Marken’s pharmaceutical client base. The system is being launched just as Marken is opening its third fully owned and staffed depot facility in Buenos Aires, Argentina.
*validated in accordance with 21 CFR part 11
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025